Combating CoV infections is a massive concern for healthcare systems, owing to the virus's high transmission rate and ability to withstand several mutations. The use of nanotechnology in the diagnosis, treatment, and prevention of COVID-19 has enormous potential. Several nano-based formulations have been demonstrated to increase antiviral medication target delivery and therapeutic efficacy. A new generation of vaccines based on various types of nanomaterials, with better antigen stability, target delivery, and controlled-release, is another promising alternative. The development of technologies for speedy, accurate, and sensitive diagnosis, the manufacturing of effective disinfectants, the delivery of mRNA vaccines into human cells, and the delivery of antiviral medicines into the body are all nanotechnology-based solutions for COVID-19 disease management.
Title : Circumventing challenges in developing CVD graphene on steels for extraordinary and durable corrosion resistance
Raman Singh, Monash University, Australia
Title : Nanomaterial-based bio-lubricant additives for improved efficiency and environmental sustainability in automotive applications
S V A R Sastry, Harcourt Butler Technical University, India
Title : Evaluating cytotoxicity of metal-doped tin oxide nanoparticles
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Lipid nanoparticles formulations: From bench scale to industrial scale
Mohammad A Obeid, RAK Medical and Health Sciences University, United Arab Emirates
Title : Controllable assembly and disassembly of microparticles under light-induced electric fields
Ao Wang, Beihang University, China
Title : Eliminating implant infections in over 40,000 patients: The impact of nanomedicine
Thomas J Webster, Hebei University of Technology, China